Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD (Nexus) This study has been completed. Sponsor: Lpath, Inc. Information provided by (Responsible Party): Lpath, Inc. September 15 Big news. Guys.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.